Ticker Details
ABBVIE INC. AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.
IPO Date:	December 14, 2012
Sector:	Healthcare
Industry:	Drug Manufacturers
Market Cap:	$449.45B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.22 | 1.14%
Avg Daily Range (30 D):	$4.03 | 1.71%
Avg Daily Range (90 D):	$3.08 | 1.39%

Institutional Daily Volume
Avg Daily Volume:	6.1M
Avg Daily Volume (30 D):	5.24M
Avg Daily Volume (90 D):	4.77M

Trade Size
Avg Trade Size (Sh.):	101
Avg Trade Size (Sh.) (30 D):	57
Avg Trade Size (Sh.) (90 D):	53

Institutional Trades
Total Institutional Trades:	65,527
Avg Institutional Trade:	$11.12M
Avg Institutional Trade (30 D):	$44.64M
Avg Institutional Trade (90 D):	$35.17M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	19

Market Closing Trades
Avg Closing Trade:	$96.55M
Avg Closing Trade (30 D):	$452.98M
Avg Closing Trade (90 D):	$347.03M
Avg Closing Volume:	799.23K

News

Jul 19, 2026 @ 12:16 AM IHE vs IXJ: Which Popular Healthcare ETF Is the Be... Source: Cory Renauer

Jul 17, 2026 @ 10:48 AM Clinical Stage Partnering Terms and Agreements in ... Source: Researchandmarkets.Com

Jul 16, 2026 @ 1:31 PM Healthcare Investing in 2026: iShares Global Healt... Source: Sarah Sidlow

Jul 15, 2026 @ 3:00 PM Autoimmune Disease Therapeutics Market Size to Rea... Source: Sns Insider

Jul 15, 2026 @ 9:13 AM Nxera Pharma Webinar for Financial Results Present... Source: Nxera Pharma

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$2.03	$.39	$1.02
Diluted EPS	$2.03	$.39	$1.02
Revenue	$62.82B	$15B	$16.62B
Gross Profit	$44.4B	$10.78B	$12.07B
Net Income / Loss	$3.64B	$697M	$1.82B
Operating Income / Loss	$15.33B	$3.99B	$4.54B
Cost of Revenue	$18.42B	$4.22B	$4.55B
Net Cash Flow	$4.22B	$4.16B	$-400M
PE Ratio